Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia

被引：0
|
作者：
Natarajan, H. [1 ]
Kumar, L. [2 ]
Bakhshi, S. [2 ]
Sharma, A. [2 ]
Velpandian, T. [1 ]
Gogia, A. [2 ]
Gupta, Y. K. [1 ]
机构：
[1] All India Inst Med Sci, Clin Pharmacol, New Delhi, India
[2] All India Inst Med Sci, Med Oncol, New Delhi, India
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw586
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
335O
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia
    Natarajan, Harivenkatesh
    Kumar, Lalit
    Bakhshi, Sameer
    Sharma, Atul
    Velpandian, Thirumurthy
    Kabra, Madhulika
    Gogia, Ajay
    Biswas, Nihar Ranjan
    Gupta, Yogendra Kumar
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 418 - 425
  • [2] Imatinib induced toxicity and its influence on cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia
    Natarajan, H.
    Kumar, L.
    Bakhshi, S.
    Sharma, A.
    Velpandian, T.
    Kabra, M.
    Gogia, A.
    Biswas, N. R.
    Gupta, Y. K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Correlation of plasma trough levels of imatinib with molecular response in patients with chronic myeloid leukemia
    Malhotra, Hemant
    Sharma, Pratibha
    Bhargava, Shipra
    Rathore, Om Singh
    Malhotra, Bharti
    Kumar, Madhu
    LEUKEMIA & LYMPHOMA, 2014, 55 (11) : 2614 - 2619
  • [4] Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib
    Ganguly, Sandip
    Lakshmaiah, K. C.
    Jacob, Linu Abraham
    Babu, Suresh
    Dasappa, Lokanatha
    Babu, K. S. Govind
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2017, 33 (01) : 82 - 86
  • [5] Performance of Sokal and Eutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed Chronic Myeloid Leukemia-Chronic Phase Patients on Imatinib
    Sandip Ganguly
    K. C. Lakshmaiah
    Linu Abraham Jacob
    Suresh Babu
    Lokanatha Dasappa
    K. S. Govind Babu
    Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 82 - 86
  • [6] Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
    Sohn, Sang Kyun
    Oh, Suk Joong
    Kim, Byung Soo
    Ryoo, Hun Mo
    Chung, Joo Seop
    Joo, Young Don
    Bang, Soo Mee
    Jung, Chul Won
    Kim, Dong Hwan
    Yoon, Sung Soo
    Kim, In Ho
    Lee, Hong Ghi
    Won, Jong Ho
    Min, Yoo Hong
    Cheong, June Won
    Park, Joon Seong
    Eom, Ki Seong
    Hyun, Myung Soo
    Kim, Min Kyoung
    Kim, Hawk
    Park, Moo Rim
    Park, Jinny
    Kim, Chul Soo
    Kim, Hyeoung Joon
    Kim, Yeo Kyeoung
    Park, Eun Kyung
    Zang, Dae Young
    Jo, Deog Yeon
    Moon, Joon Ho
    Park, Seon Yang
    LEUKEMIA & LYMPHOMA, 2011, 52 (06) : 1024 - 1029
  • [7] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
  • [8] Prospective study of trough imatinib levels in newly diagnosed chronic myeloid leukaemia (CML) patients and its correlation with response
    Chandra, D.
    Agbuduwe, C.
    Griffiths, M.
    Mason, J.
    Borrow, J.
    Rose, S.
    Piechocki, K.
    Craddock, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 125 - 125
  • [9] Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia
    Picard, Stephane
    Titier, Karine
    Etienne, Gabriel
    Bouchet, Stphane
    Ducint, Dominique
    Bernard, Marie-Agnes
    Lassalle, Regis
    Marit, Gerald
    Reiffers, Josy
    Begaud, Bernard
    Moore, Nicholas
    Molimard, Mathieu
    Mahon, Francois-Xavier
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 481 - 481
  • [10] Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia
    Picard, Stephane
    Titier, Karine
    Etienne, Gabriel
    Teilhet, Ernmanuelle
    Ducint, Dominique
    Bernard, Marie-Agnes
    Lassalle, Regis
    Marit, Gerald
    Reiffers, Josy
    Begaud, Bernard
    Moore, Nicholas
    Molimard, Mathieu
    Mahon, Francois-Xavier
    BLOOD, 2007, 109 (08) : 3496 - 3499
12345